CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase II, Multi-Center, Open-Label Study of Tremelimumab Monotherapy in Patients With Advanced Solid Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02527434
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:28.682218+00:00
- Published At
- 2019-03-05T00:00:00+00:00
- Record Updated At
- 2023-11-15
- Results Posted At
- 2019-03-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Urothelial Bladder Cancer", "Triple-negative Breast Cancer", "Pancreatic Ductal Adenocarcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-11-15"- protocolSection.identificationModule.nctId
"NCT02527434"- protocolSection.identificationModule.officialTitle
"A Phase II, Multi-Center, Open-Label Study of Tremelimumab Monotherapy in Patients With Advanced Solid Tumors"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-03-05"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.